Literature DB >> 19804483

PAR4: a new role in the modulation of visceral nociception.

S Bradesi1.   

Abstract

Protease-activated receptors (PARs) are a family of G-protein-coupled receptors with a widespread distribution that are involved in various physiological functions including inflammation and nociception. In a recent study in Neurogastroenterology and Motility, Augé et al. describe for the first time the presence of PAR4 on visceral primary afferent neurons and its role in modulating colonic nociceptive responses, colonic hypersensitivity and primary afferent responses to PAR2 and Transient Receptor Potential Vanilloid-4 (TRPV4). Using the model of visceromotor response (VMR) to colorectal distension (CRD), they show that a PAR4 agonist delivered into the colon lumen decreases basal visceral response to CRD and reduces the exacerbated VMR to CRD induced by treatment with PAR2 or TRPV4 agonists. In isolated sensory neurons, they show that a PAR4 agonist inhibits calcium mobilization induced by PAR2 or TRPV4 agonists. Finally, they describe increased pain behaviour evoked by luminal application of mustard oil in PAR4 deficient mice compared to wild type controls. The newly discovered role of PAR4 in modulating visceral pain adds to our growing understanding of the contribution of colonic proteases and PARs to the mechanisms involved in colonic hypersensitivity and their potential role as therapeutic targets for irritable bowel syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19804483      PMCID: PMC2771625          DOI: 10.1111/j.1365-2982.2009.01373.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  20 in total

Review 1.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

2.  Proteinase-activated receptors, targets for kallikrein signaling.

Authors:  Katerina Oikonomopoulou; Kristina K Hansen; Mahmoud Saifeddine; Illa Tea; Michael Blaber; Sachiko I Blaber; Isobel Scarisbrick; Patricia Andrade-Gordon; Graeme S Cottrell; Nigel W Bunnett; Eleftherios P Diamandis; Morley D Hollenberg
Journal:  J Biol Chem       Date:  2006-08-02       Impact factor: 5.157

3.  Role for protease activity in visceral pain in irritable bowel syndrome.

Authors:  Nicolas Cenac; Christopher N Andrews; Marinella Holzhausen; Kevin Chapman; Graeme Cottrell; Patricia Andrade-Gordon; Martin Steinhoff; Giovanni Barbara; Paul Beck; Nigel W Bunnett; Keith A Sharkey; Jose Geraldo P Ferraz; Eldon Shaffer; Nathalie Vergnolle
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

4.  A dual thrombin receptor system for platelet activation.

Authors:  M L Kahn; Y W Zheng; W Huang; V Bigornia; D Zeng; S Moff; R V Farese; C Tam; S R Coughlin
Journal:  Nature       Date:  1998-08-13       Impact factor: 49.962

5.  Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents.

Authors:  Steeve Houle; Martin D Papez; Mara Ferazzini; Morley D Hollenberg; Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

6.  Cloning and characterization of human protease-activated receptor 4.

Authors:  W F Xu; H Andersen; T E Whitmore; S R Presnell; D P Yee; A Ching; T Gilbert; E W Davie; D C Foster
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

7.  Triggering of proteinase-activated receptor 4 leads to joint pain and inflammation in mice.

Authors:  Jason J McDougall; Chunfen Zhang; Laurie Cellars; Eva Joubert; Chantelle M Dixon; Nathalie Vergnolle
Journal:  Arthritis Rheum       Date:  2009-03

8.  Protease-activated receptor-4 (PAR 4): a role as inhibitor of visceral pain and hypersensitivity.

Authors:  C Augé; D Balz-Hara; M Steinhoff; N Vergnolle; N Cenac
Journal:  Neurogastroenterol Motil       Date:  2009-04-20       Impact factor: 3.598

Review 9.  Mechanisms of disease: protease functions in intestinal mucosal pathobiology.

Authors:  Toni M Antalis; Terez Shea-Donohue; Stefanie N Vogel; Cynthia Sears; Alessio Fasano
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2007-07

10.  Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation.

Authors:  S Asfaha; N Cenac; S Houle; C Altier; M D Papez; C Nguyen; M Steinhoff; K Chapman; G W Zamponi; N Vergnolle
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

View more
  4 in total

Review 1.  New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature review.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Honggang Zheng; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

Review 2.  Protease-activated receptor 4: a critical participator in inflammatory response.

Authors:  Qiang Fu; Jing Cheng; Yebo Gao; Yonglei Zhang; Xiaobing Chen; Jianguo Xie
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

3.  A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide Agonist.

Authors:  Juliet Mwirigi; Moeno Kume; Shayne N Hassler; Ayesha Ahmad; Pradipta R Ray; Changyu Jiang; Alexander Chamessian; Nakleh Mseeh; Breya P Ludwig; Benjamin D Rivera; Marvin T Nieman; Thomas Van de Ven; Ru-Rong Ji; Gregory Dussor; Scott Boitano; Josef Vagner; Theodore J Price
Journal:  J Pain       Date:  2021-01-09       Impact factor: 5.383

4.  Proteinase Activated Receptor 4 in the Jejunum of Healthy Horses and of Horses With Epiploic Hernia.

Authors:  Carlotta Lambertini; Cristiano Bombardi; Augusta Zannoni; Chiara Bernardini; Francesco Dondi; Maria Morini; Riccardo Rinnovati; Alessandro Spadari; Noemi Romagnoli
Journal:  Front Vet Sci       Date:  2020-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.